The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It cut drug costs by billions but also opened doors to patent abuse.
VIEW MOREAfter the first generic enters the market, a cascade of competitors follows, triggering steep price drops and supply shortages. Learn how patent rules, authorized generics, and manufacturing bottlenecks shape the chaotic race to sell the same drug.
VIEW MOREThe Hatch-Waxman Act revolutionized U.S. drug access by creating a fast, affordable path for generic drugs. It balances innovation with competition, saving billions annually and making medications accessible to millions.
VIEW MORE